Company Filing History:
Years Active: 1992-2002
Title: The Innovations of Serge Burner
Introduction
Serge Burner is a notable inventor based in Durmenach-Ferrette, France. He has made significant contributions to the field of pharmaceuticals, particularly in the development of compounds that modulate neuronal activity and plasticity. With a total of 6 patents to his name, his work continues to impact the scientific community.
Latest Patents
Among his latest patents are the Quinolin-4-yl derivatives, which include phenyl substituted quinolin 4-yl derivatives and pharmaceutical compositions with activity as NMDA-receptor subtype selective blockers. These compounds are designed to modulate neuronal activity and plasticity, showcasing his innovative approach to addressing neurological challenges.
Career Highlights
Serge Burner is currently associated with Hoffmann-La Roche Inc., a leading company in the pharmaceutical industry. His work at this organization has allowed him to focus on groundbreaking research and development in the field of medicinal chemistry.
Collaborations
Throughout his career, Burner has collaborated with esteemed colleagues such as Alexander Alanine and Marie-Paule Heitz Neidhart. These partnerships have fostered a collaborative environment that enhances the quality and impact of their research.
Conclusion
Serge Burner's contributions to the field of pharmaceuticals through his innovative patents and collaborations highlight his role as a significant inventor. His work continues to influence the development of new therapeutic approaches.